Your institution may have access to this item. Find your institution then sign in to continue.
Title
Triple Therapy in Type 2 Diabetes: Insulin Glargine or Rosiglitazone Added to Combination Therapy of Sulfonylurea Plus Metformin in Insulin-Naïve Patients.
A letter to the editor in response to the article "Triple Therapy in Type 2 Diabetes: Insulin Glargine or Rosiglitazone Added to Combination Therapy of Sulfonylurea Plus Metformin in Insulin-naïve patients," by J. Rosenstock, D. Sugimoto et al. in the 2006 issue is presented.